Affordable Access

Human papillomavirus DNA testing for cervical cancer screening in low-resource settings.

Authors
Type
Published Article
Journal
Journal of the National Cancer Institute
Publication Date
Volume
92
Issue
10
Pages
818–825
Identifiers
PMID: 10814677
Source
Medline
License
Unknown

Abstract

HPV DNA testing has a sensitivity equivalent to, or better than, that of cytology. Since HPV DNA testing programs may be easier to implement than cytologic screening, HPV testing should be considered for primary cervical cancer screening in low-resource settings.

Statistics

Seen <100 times